Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/28/2026 06:41 PDT] RGC Expected to Trade Down Short Term
• [05/13/2026 10:29 PDT] RGC SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [05/11/2026 07:03 PDT] RGC Expected to Trade Up After Bullish Patterns Develop
• [05/05/2026 07:09 PDT] RGC Expected to Trade Up After Bullish Patterns Develop